ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1575

The Association between Salivary Gland Ultrasonography and Clinical Manifestation in Patients with Early Primary Sjögren’s Syndrome

Yen-Fu Chen1 and Yao-Fan Fang2, 1Division of Rheumatology, Allergy and Immunology, Chang Gung Memorial Hospital, Taoyuan, Taiwan, 2Chang-Gung Memorial Hospital, Taoyuan city, Taiwan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Sjogren's syndrome and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Sjögren's Syndrome – Basic and Clinical Science Poster

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

To investigate the clinical manifestations in patients with early primary Sjögren¡¦s syndrome based on different severity score under salivary gland ultrasonography.

Methods:

We enrolled 44 newly diagnosed patients with early primary Sjögren¡¦s syndrome at Chang Gung Memorial Hospital in Taiwan (Figure 1). We divided patients into two groups according to baseline salivary gland ultrasonography grade scores. Severe group was defined score 2-3 and mild group was score 0-1. Student¡¦s t-test was used to compare the two groups.

Results:

The mean age of patients were 50.02 years old. The mean duration of sicca symptoms were 0.86 years. The mean score of ESSPRI and ESSDAI were 16.98 and 3.35, respectively. Higher rheumatoid factor titer was statistically significant in severe group(p=0.04). Higher titer of autoantibodies such as anti-SSA/SSB, anti-dsDNA and IgG were found in severe group but not reached significant. However, ESSDAI and ESSPRI was not associated with sonography severity score.  

Conclusion: ¡@

Only higher rheumatoid factor titer is associated with higher salivary gland ultrasonography grade score. However, severe ultrasonography grade score was not related to clinical disease activity such as ESSDAI. Previous study showed salivary gland ultrasonography as a good diagnostic tool of Sjögren¡¦s syndrome and as a predictor of clinical activity in Sjogren’s syndrome, but the disease mean duration is around 7.5 years. Our study enrolled patients with early primary Sjögren¡¦s syndrome with mean disease duration less than one year. The clinical manifestations are not associated with salivary ultrasonography severity score in early primary Sjögren¡¦s syndrome.


Disclosure: Y. F. Chen, None; Y. F. Fang, None.

To cite this abstract in AMA style:

Chen YF, Fang YF. The Association between Salivary Gland Ultrasonography and Clinical Manifestation in Patients with Early Primary Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-association-between-salivary-gland-ultrasonography-and-clinical-manifestation-in-patients-with-early-primary-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-association-between-salivary-gland-ultrasonography-and-clinical-manifestation-in-patients-with-early-primary-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology